Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Inogen Inc (INGN)

Inogen Inc (INGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Inogen Inc 500 Cummings Center Suite 2800 Beverly MA 01915 USA

www.inogen.com Employees: 753 P: 855-631-2438

Sector:

Medical

Description:

Inogen Inc. develops, manufactures and markets POC. POCs are used by patients who suffer from chronic respiratory conditions and need long-term oxygen therapy. POCs concentrate the air around the patient, filter out the nitrogen and other unwanted substances and deliver oxygen. The company provides oxygen concentrator solutions for portable and stationary use. Inogen's flagship product, One G4 is a single-solution POC.

Key Statistics

Overview:

Market Capitalization, $K 169,383
Enterprise Value, $K 64,363
Shares Outstanding, K 27,232
Float, K 26,834
% Float 98.54%
Short Interest, K 973
Short Float 3.57%
Days to Cover 3.64
Short Volume Ratio 0.43
% of Insider Shareholders 1.46%
% of Institutional Shareholders 89.94%

Financials:

Annual Sales, $ 348,670 K
Annual Net Income, $ -22,750 K
Last Quarter Sales, $ 81,720 K
Last Quarter Net Income, $ -7,130 K
EBIT, $ -30,220 K
EBITDA, $ -9,560 K

Growth:

1-Year Return -18.91%
3-Year Return -50.87%
5-Year Return -87.78%
5-Year Revenue Growth 13.02%
5-Year Earnings Growth -218.52%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.20 on 11/05/25
Next Earnings Date 05/06/26
Earnings Per Share ttm -0.86
EPS Growth vs. Prev Qtr -30.00%
EPS Growth vs. Prev Year 36.59%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

INGN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -11.56%
Return-on-Assets % -7.42%
Profit Margin % -6.52%
Debt/Equity 0.00
Price/Sales 0.50
Price/Cash Flow N/A
Price/Book 0.90
Book Value/Share 7.08
Interest Coverage -0.86
60-Month Beta 1.77
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar